Literature DB >> 11472875

Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors.

J I Satoh1, Y Kuroda.   

Abstract

Increasing evidence has indicated that proinflammatory cytokines such as TNF-alpha and IL-1beta, produced by activated microglia and astrocytes, play a key role in progressive degeneration of the nigrostriatal dopaminergic neurons in Parkinson's disease (PD). Since alpha-synuclein is a major component of Lewy bodies in PD brains, we studied the constitutive and cytokine/neurotrophic factor-regulated expression of alpha-synuclein in cultured human neurons by Northern blot and Western blot analyses. The constitutive expression of alpha-synuclein mRNA was identified in a variety of human neural and non-neural cell lines. The levels of alpha-synuclein expression were elevated markedly in NTera2 teratocarcinoma cells following retinoic acid-induced neuronal differentiation, accompanied with an increased expression of synphilin-1, while they were unaltered in NTera2-derived differentiated neurons by exposure to TNF-alpha, IL-1beta, BDNF or GDNF. These results indicate that alpha-synuclein expression in human neurons is up-regulated during differentiation, but is unaffected by a panel of cytokines and neurotrophic factors which are supposed to be involved in the nigral neuronal death and survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472875     DOI: 10.1016/s1353-8020(00)00075-4

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

Review 1.  Neurotrophic factors for the investigation and treatment of movement disorders.

Authors:  Justo Garcia De Yébenes; Marina Sánchez; Maria Angeles Mena
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

2.  Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.

Authors:  Maria Angeliki S Pavlou; Nicoló Colombo; Sandra Fuertes-Alvarez; Sarah Nicklas; Laura Gonzalez Cano; Maria C Marín; Jorge Goncalves; Jens C Schwamborn
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

3.  Angelica Sinensis attenuates inflammatory reaction in experimental rat models having spinal cord injury.

Authors:  Jun Xu; Xiao-Qiang E; Hui-Yong Liu; Jun Tian; Jing-Long Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice.

Authors:  Giuseppina Cantarella; Giulia Di Benedetto; Mimmo Scollo; Irene Paterniti; Salvatore Cuzzocrea; Paolo Bosco; Giuseppe Nocentini; Carlo Riccardi; Renato Bernardini
Journal:  Neuropsychopharmacology       Date:  2010-01-27       Impact factor: 7.853

5.  Interleukin-1 mediates Alzheimer and Lewy body pathologies.

Authors:  W Sue T Griffin; Ling Liu; Yuekui Li; Robert E Mrak; Steven W Barger
Journal:  J Neuroinflammation       Date:  2006-03-16       Impact factor: 8.322

Review 6.  Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.